MOSCOW, March 15. /TASS/. A medication for treating the Ebola hemorrhagic fever has been developed in Russia, the research will be completed in the near future, Russian Healthcare Minister Veronika Skvortsova told reporters on Tuesday.
"Currently, the treatment medication has been developed in Russia," she said.
According to Skvortsova, "the research will be completed in the near future, and it will be registered."
"At the preliminary stages it shows a very high efficiency, making it possible to interrupt the infection process and, consequently, improve the survival rate of the primates that have been infected with Ebola," she said.
Russian specialists earlier developed a vaccine for this virus, to date it is the world’s only preventive medication against Ebola that has passed the state registration procedure.
The Ebola virus disease, also known as the Ebola hemorrhagic fever, is a severe illness in humans, often fatal, according to the WHO. The virus is passed on to people from wild animals and can be transmitted from humans to humans.